KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Ingredients (ALTO) Receivables (2016 - 2025)

Alto Ingredients (ALTO) has 15 years of Receivables data on record, last reported at $54.8 million in Q3 2025.

  • For Q3 2025, Receivables rose 16.79% year-over-year to $54.8 million; the TTM value through Sep 2025 reached $54.8 million, up 16.79%, while the annual FY2024 figure was $58.2 million, 0.87% down from the prior year.
  • Receivables reached $54.8 million in Q3 2025 per ALTO's latest filing, up from $49.2 million in the prior quarter.
  • Across five years, Receivables topped out at $455.4 million in Q2 2022 and bottomed at $59000.0 in Q2 2023.
  • Average Receivables over 5 years is $92.6 million, with a median of $60.4 million recorded in 2021.
  • Peak YoY movement for Receivables: plummeted 99.99% in 2023, then surged 100128.81% in 2024.
  • A 5-year view of Receivables shows it stood at $64.3 million in 2021, then increased by 24.57% to $80.1 million in 2022, then plummeted by 94.63% to $4.3 million in 2023, then skyrocketed by 1253.25% to $58.2 million in 2024, then fell by 5.94% to $54.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $54.8 million in Q3 2025, $49.2 million in Q2 2025, and $65.5 million in Q1 2025.